Skip Navigation

98308: A Phase III Randomized, Double-Blind, Placebo Controlled Trial of North American Ginseng Extract (CVT-E002; COLD-fX®) to Prevent Respiratory Infection and Reduce Antibiotic Use in Patients with Chronic Lymphocytic Leukemia (1 credit)


This study is permanently closed as of 01/01/2009. The accrual goal has been achieved. This study was terminated on 11/10/2011.
  

   Appendices   •   Archived Amendments   •   Adverse Events       

Quick Reference

Research Base

Phone 336-716-0891
Fax 336-716-6275

E-mail
resbase@wakehealth.edu

Medical Center Boulevard, 525@Vine 4th floor
Box 573152
Winston-Salem, NC 27157
Find A Doctor Ways to Give
Last Updated: 02-29-2012
Six Wake Forest Baptist Specialties Earn U.S. News RankingsComprehensive Cancer Centers National Designation is Renewed2017-2018 Best DoctorsMagnet Hospital RecognitionJoint Commission Report

Disclaimer: The information on this website is for general informational purposes only and SHOULD NOT be relied upon as a substitute for sound professional medical advice, evaluation or care from your physician or other qualified health care provider.

© Wake Forest Baptist Medical Center, Medical Center Boulevard, Winston-Salem, NC 27157. All Rights Reserved.